# Immatics N.V. (IMTX): MoatMap facts

As of 14 Oct 2026. Research data, not investment advice.

As of 14 Oct 2026, MoatMap's StockRank for Immatics N.V. (IMTX) is 8/100, ranked against 24,000+ stocks in 35 markets (Quality 22, Value 29, Momentum 27, each scored against its sector).

- StockRank: 8/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 22, Value 29, Momentum 27: each a 0-100 percentile within the stock's sector.
- Position: #24,845 overall, #2,378 in Healthcare.
- Listing: United States, NCM; Healthcare / Biotechnology.
- Last close: 7.21 USD on 12 Oct 2026.
- Insider filings, last 180 days: directors bought USD 7.5M.

Source: https://moatmap.ai/stock/IMTX
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker